Resina draconis (bright red resin isolated from Dracaena cochinchinensis, RD) has been clinically used for treatment of myocardial ischemia (MI) for manyyears. However, the mechanisms of its pharmacological action on MI are still poorly understood. This study aimed to characterize the plasma